Using computational tools and virtual screening, researchers at the Center for Redox Processes in Biomedicine (Redoxoma) have ...
A study identifies senolytic compounds that can inhibit specific brain enzymes associated with Alzheimer’s disease (AD) while ...
Small-molecule enzyme-inhibitors often display insufficient affinity and selectivity for their targets causing unwanted side effects when used as drugs. Molecularly imprinted polymers prepared ...
This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target ...
Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...
In epidemiological, genetic, and intervention studies, mixed dyslipidaemia, characterised by elevated concentrations of total ...
11d
News-Medical.Net on MSNNew enzyme target could lead to breakthrough therapies for Lyme diseaseResearchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, ...
For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled cell growth, cancer can emerge.
Hosted on MSN10mon
Unveiling a novel AAK1 inhibitor: How chemical proteomics unlock therapeutic potentialTokumitsu. "By leveraging kinase inhibitor development methods, starting with identifying enzymes that interact with existing inhibitors, promises a rapid drug discovery cycle with protein kinases ...
Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
Cinnamon and its byproducts have been used for many years because of their antidiabetic effect. In a joint study conducted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results